Featured News Image news | May 16 2024 Wu Tsai Neurosciences Institute How we remember, why we forget This week on From Our Neurons to Yours, we talk with memory expert Anthony Wagner about the nature of memory and how to improve it Image news | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter our perceptions? (Part ... This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. How do tiny quantities of these chemicals alter our perception of reality? And what does that say about... reality? Image news | May 7 2024 Wu Tsai Neuro Exploring MRI's role in neuroscience research on model organisms Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants. Image news | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine News Filter & Sort Sort by ThemeNeuroHealth NeuroDiscovery News TypePodcast episodes Press coverage Research news Featured News Sort by Newest to oldest Oldest to newest Image news | Feb 15 2024 From Our Neurons to Yours OCD and Ketamine This week, we're taking a deep dive with Psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time Image news | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest. Image news | Jan 26 2023 From Our Neurons to Yours Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?" Image news | Jan 9 2023 Wu Tsai Neuro The rebirth of psychedelic medicine Researchers at the the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. news | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.
Image news | May 16 2024 Wu Tsai Neurosciences Institute How we remember, why we forget This week on From Our Neurons to Yours, we talk with memory expert Anthony Wagner about the nature of memory and how to improve it
Image news | May 9 2024 Wu Tsai Neurosciences Institute Psychedelics Inside Out: How do LSD and psilocybin alter our perceptions? (Part ... This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about how psychedelics work in the brain. How do tiny quantities of these chemicals alter our perception of reality? And what does that say about... reality?
Image news | May 7 2024 Wu Tsai Neuro Exploring MRI's role in neuroscience research on model organisms Recognizing the potential for wider application in small-animal neuroscience research, the Neurosciences Preclinical Imaging Lab (NPIL) at Wu Tsai Neuro hosted its 3rd annual symposium and named the recipients of its Pilot Grants.
Image news | May 2 2024 Wu Tsai Neurosciences Institute Psychedelics, placebo, and anesthetic dreams This week on From Our Neurons to Yours, we talk with anesthesiologist Boris Heifets about studies that could change our understanding of the renaissance in psychedelic medicine
Image news | Feb 15 2024 From Our Neurons to Yours OCD and Ketamine This week, we're taking a deep dive with Psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time
Image news | Oct 30 2023 Medscape Ketamine No Better for Depression Than Placebo? Ketamine was no more effective than placebo in reducing depressive symptoms in surgical patients with major depression, results of a new study, which contradict prior research, suggest.
Image news | Jan 26 2023 From Our Neurons to Yours Psychedelics and Empathy Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?"
Image news | Jan 9 2023 Wu Tsai Neuro The rebirth of psychedelic medicine Researchers at the the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
news | Aug 29 2018 NPR Ketamine, A Promising Depression Treatment, Seems To Act Like An Opioid A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.